Klick Health

Bayer blazes trail with new Facebook branded claim ad


Read More

This is week two of the Facebook ISI ad story, but it's big news when pharma can reach the 72% of online Americans who use Facebook with more than just reminder ads. This story talks about the Bayer ad shown at Digital Pharma East:

While some pharmas already do that in banner ads, it had not been done inside Facebook ads until this campaign, said Craig Hashi, Facebook Health client partner, who–along with Ozgun Demir, associate director of emarketing at Bayer–talked about the work at the Digital Pharma East conference last week.


Image of Bayer ad from FiercePharma story

Demir talked about the benefits of the campaign:

Bayer uses Facebook’s targeting to reach people on the platform who are interested in MS-related information, Demir said. The end result? A 96% decrease in costs per lead. It also increases the number of leads, so much so that it has at times overwhelmed the nursing staff, he said.

Anyone who wants a demo of this technique in action can talk to their Klick rep and we have posted a description of how it works on our blog (or shoot me an email and I can walk you through it -Ed.).

Also, you never know, Canvas Ads might be the next Pharma innovation on Facebook (just sayin’ -Ed.).

Other stories from the Fierce network:

Source: FiercePharma

This story first appeared in the Klick Wire, delivered 7AM every Monday. Sign up to get the Wire today!

More About the Author

Klick Wire

This is the Klick Wire blog account. Here you will find archived versions of all your favorite Klick Wire stories. To get these stories delivered to your inbox every week, use the sign up form at the bottom of this page.

More from this author

Go from news to action. Klick Wire

Weekly Digital Health Newsletter

Klick Health will NEVER spam you. Read our privacy policy

Thank you! You're now signed up to get the Klick Wire every week - news from the world of digital health marketing.

Sorry there seems to be a problem. Please try again later.